These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 24225352)

  • 1. Pulse pressure is associated with Alzheimer biomarkers in cognitively normal older adults.
    Nation DA; Edland SD; Bondi MW; Salmon DP; Delano-Wood L; Peskind ER; Quinn JF; Galasko DR
    Neurology; 2013 Dec; 81(23):2024-7. PubMed ID: 24225352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Social Networks and Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Pathology in Cognitively Intact Older Adults: The CABLE Study.
    Ma YH; Wang YY; Tan L; Xu W; Shen XN; Wang HF; Hou XH; Cao XP; Bi YL; Dong Q; Yang JL; Yu JT
    J Alzheimers Dis; 2021; 81(1):263-272. PubMed ID: 33749650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulse pressure in relation to tau-mediated neurodegeneration, cerebral amyloidosis, and progression to dementia in very old adults.
    Nation DA; Edmonds EC; Bangen KJ; Delano-Wood L; Scanlon BK; Han SD; Edland SD; Salmon DP; Galasko DR; Bondi MW;
    JAMA Neurol; 2015 May; 72(5):546-53. PubMed ID: 25822631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of clusterin in amyloid-β-associated neurodegeneration.
    Desikan RS; Thompson WK; Holland D; Hess CP; Brewer JB; Zetterberg H; Blennow K; Andreassen OA; McEvoy LK; Hyman BT; Dale AM;
    JAMA Neurol; 2014 Feb; 71(2):180-7. PubMed ID: 24378367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CSF tau and β-amyloid predict cerebral synucleinopathy in autopsied Lewy body disorders.
    Irwin DJ; Xie SX; Coughlin D; Nevler N; Akhtar RS; McMillan CT; Lee EB; Wolk DA; Weintraub D; Chen-Plotkin A; Duda JE; Spindler M; Siderowf A; Hurtig HI; Shaw LM; Grossman M; Trojanowski JQ
    Neurology; 2018 Mar; 90(12):e1038-e1046. PubMed ID: 29467305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated Inflammatory Markers and Arterial Stiffening Exacerbate Tau but Not Amyloid Pathology in Older Adults with Mild Cognitive Impairment.
    Clark AL; Weigand AJ; Thomas KR; Solders SK; Delano-Wood L; Bondi MW; Bernier RA; Sundermann EE; Banks SJ; Bangen KJ;
    J Alzheimers Dis; 2021; 80(4):1451-1463. PubMed ID: 33682714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Odor identification as a biomarker of preclinical AD in older adults at risk.
    Lafaille-Magnan ME; Poirier J; Etienne P; Tremblay-Mercier J; Frenette J; Rosa-Neto P; Breitner JCS;
    Neurology; 2017 Jul; 89(4):327-335. PubMed ID: 28659431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Markers of neuroinflammation associated with Alzheimer's disease pathology in older adults.
    Popp J; Oikonomidi A; Tautvydaitė D; Dayon L; Bacher M; Migliavacca E; Henry H; Kirkland R; Severin I; Wojcik J; Bowman GL
    Brain Behav Immun; 2017 May; 62():203-211. PubMed ID: 28161476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of specific amyloid-β oligomers with tau in cerebrospinal fluid from cognitively normal older adults.
    Handoko M; Grant M; Kuskowski M; Zahs KR; Wallin A; Blennow K; Ashe KH
    JAMA Neurol; 2013 May; 70(5):594-9. PubMed ID: 23479202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. APOE ε4 moderates abnormal CSF-abeta-42 levels, while neurocognitive impairment is associated with abnormal CSF tau levels in HIV+ individuals - a cross-sectional observational study.
    Cysique LA; Hewitt T; Croitoru-Lamoury J; Taddei K; Martins RN; Chew CS; Davies NN; Price P; Brew BJ
    BMC Neurol; 2015 Apr; 15():51. PubMed ID: 25880550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein E epsilon4 does not modulate amyloid-β-associated neurodegeneration in preclinical Alzheimer disease.
    Desikan RS; McEvoy LK; Holland D; Thompson WK; Brewer JB; Aisen PS; Andreassen OA; Hyman BT; Sperling RA; Dale AM;
    AJNR Am J Neuroradiol; 2013 Mar; 34(3):505-10. PubMed ID: 22976236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum Uric Acid May Aggravate Alzheimer's Disease Risk by Affecting Amyloidosis in Cognitively Intact Older Adults: The CABLE Study.
    Li LL; Ma YH; Bi YL; Sun FR; Hu H; Hou XH; Xu W; Shen XN; Dong Q; Tan L; Yang JL; Yu JT
    J Alzheimers Dis; 2021; 81(1):389-401. PubMed ID: 33814427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lower Left Ventricular Ejection Fraction Relates to Cerebrospinal Fluid Biomarker Evidence of Neurodegeneration in Older Adults.
    Kresge HA; Liu D; Gupta DK; Moore EE; Osborn KE; Acosta LMY; Bell SP; Pechman KR; Gifford KA; Mendes LA; Wang TJ; Blennow K; Zetterberg H; Hohman TJ; Jefferson AL
    J Alzheimers Dis; 2020; 74(3):965-974. PubMed ID: 32144980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time Trends of Cerebrospinal Fluid Biomarkers of Neurodegeneration in Idiopathic Normal Pressure Hydrocephalus.
    Lukkarinen H; Tesseur I; Pemberton D; Van Der Ark P; Timmers M; Slemmon R; Janssens L; Streffer J; Van Nueten L; Bottelbergs A; Rauramaa T; Koivisto AM; Herukka SK; Korhonen VE; Junkkari A; Hiltunen M; Engelborghs S; Blennow K; Zetterberg H; Kolb HC; Leinonen V
    J Alzheimers Dis; 2021; 80(4):1629-1642. PubMed ID: 33720890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Diagnostic Performances Between Cerebrospinal Fluid Biomarkers and Amyloid PET in a Clinical Setting.
    Jung NY; Kim ES; Kim HS; Jeon S; Lee MJ; Pak K; Lee JH; Lee YM; Lee K; Shin JH; Ko JK; Lee JM; Yoon JA; Hwang C; Choi KU; Lee EC; Seong JK; Huh GY; Kim DS; Kim EJ
    J Alzheimers Dis; 2020; 74(2):473-490. PubMed ID: 32039853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive impairment in late-life bipolar disorder is not associated with Alzheimer's disease pathological signature in the cerebrospinal fluid.
    Forlenza OV; Aprahamian I; Radanovic M; Talib LL; Camargo MZ; Stella F; Machado-Vieira R; Gattaz WF
    Bipolar Disord; 2016 Feb; 18(1):63-70. PubMed ID: 26876913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Onset of Preclinical Alzheimer Disease in Monozygotic Twins.
    Konijnenberg E; Tomassen J; den Braber A; Ten Kate M; Yaqub M; Mulder SD; Nivard MG; Vanderstichele H; Lammertsma AA; Teunissen CE; van Berckel BNM; Boomsma DI; Scheltens P; Tijms BM; Visser PJ
    Ann Neurol; 2021 May; 89(5):987-1000. PubMed ID: 33583080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma β
    Huang YM; Ma YH; Gao PY; Wang ZB; Huang LY; Hou JH; Tan L; Yu JT
    Alzheimers Res Ther; 2023 Apr; 15(1):69. PubMed ID: 37005674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of analytical platforms for cerebrospinal fluid measures of β-amyloid 1-42, total tau, and p-tau181 for identifying Alzheimer disease amyloid plaque pathology.
    Fagan AM; Shaw LM; Xiong C; Vanderstichele H; Mintun MA; Trojanowski JQ; Coart E; Morris JC; Holtzman DM
    Arch Neurol; 2011 Sep; 68(9):1137-44. PubMed ID: 21555603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects.
    Toledo JB; Zetterberg H; van Harten AC; Glodzik L; Martinez-Lage P; Bocchio-Chiavetto L; Rami L; Hansson O; Sperling R; Engelborghs S; Osorio RS; Vanderstichele H; Vandijck M; Hampel H; Teipl S; Moghekar A; Albert M; Hu WT; Monge Argilés JA; Gorostidi A; Teunissen CE; De Deyn PP; Hyman BT; Molinuevo JL; Frisoni GB; Linazasoro G; de Leon MJ; van der Flier WM; Scheltens P; Blennow K; Shaw LM; Trojanowski JQ;
    Brain; 2015 Sep; 138(Pt 9):2701-15. PubMed ID: 26220940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.